Q-omics provides the consensus-scored RNA5SP154 profile across patient tissues and cancer cell-line models. RNA5SP154 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in KIRP. Among the 18 cancer types available for tumor–normal comparison, RNA5SP154 is differentially expressed in 8, with the highest sampling consensus in KICH. Additionally, RNA5SP154 RNA expression shows 12,343 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight KIRP, KICH, and THYM as cancer lineages where RNA5SP154 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNA5SP154 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNA5SP154 survival associations across molecular data types. RNA5SP154 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNA5SP154 RNA expression–survival associations across cancer types. High RNA5SP154 expression shows unfavorable associations in ACC, CHOL and BRCA, but favorable associations in KIRP, KIRC and READ. The KIRP Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify KIRP as the clearest survival context for RNA5SP154 RNA expression.
This table summarizes RNA5SP154 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for RNA5SP154. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNA5SP154 shows lower tumor expression in KICH, BRCA, UCEC, LUAD and THCA and higher tumor expression in HNSC. The KICH box plot shows higher RNA5SP154 RNA expression in normal versus tumor tissue (log2 FC = −1.827, t-test p < 0.001).
This table shows molecular features associated with RNA5SP154 in patient tissues and cancer cell lines. In patient samples, RNA5SP154 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set.
